The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CT perfusion as an early biomarker of treatment efficacy in advanced ovarian cancer: An ECOG-ACRIN and NRG GOG study.
 
Ting-Yim Lee
Research Funding - GE Healthcare
Patents, Royalties, Other Intellectual Property - GE Healthcare
 
Chaan S. Ng
Research Funding - GE Healthcare
 
Zheng Zhang
No Relationships to Disclose
 
Susanna Lee
Research Funding - Syndax
 
Helga Marques
No Relationships to Disclose
 
Kyle Burgers
No Relationships to Disclose
 
Feng Su
No Relationships to Disclose
 
Joseph Bauza
No Relationships to Disclose
 
Robert S. Mannel
Consulting or Advisory Role - AstraZeneca (Inst); Endocyte (Inst); MedImmune (Inst); Oxigene (Inst)
 
Joan L. Walker
Consulting or Advisory Role - CritiTech; Insys Therapeutics
Research Funding - Abbott Laboratories
 
Warner King Huh
Consulting or Advisory Role - Merck; Thevax
 
Stephen C. Rubin
No Relationships to Disclose
 
Paul DiSilvestro
No Relationships to Disclose
 
Lainie P. Martin
Consulting or Advisory Role - Clovis Oncology
Research Funding - Abbvie (Inst); Clovis Oncology (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); TetraLogic Pharmaceuticals (Inst); Teva (Inst)
 
John K. Chan
No Relationships to Disclose
 
Michael A. Bookman
Employment - US Oncology
Leadership - US Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Boston Biomedical; Endocyte; Genentech/Roche; Gradalis; Novartis; Oxigene; Sanofi
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Boehringer Ingelheim; Endocyte; Genentech/Roche; Gradalis; Novartis; Oxigene; Sanofi
 
Robert L. Coleman
Honoraria - NCCN
Consulting or Advisory Role - Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche
Research Funding - Amgen; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merrimack; OncoMed
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Gradalis; Merck; Merrimack; Millennium